Home LiteratureArticle Details
PMID: 14691730 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval.

American journal of human genetics ·Vol. 74 ·No. 1 ·2004-01-00 ·Pages 11-9

Zimprich A, Müller-Myhsok B, Farrer M, Leitner P, Sharma M, Hulihan M, Lockhart P, Strongosky A, Kachergus J, Calne DB, Stoessl J, Uitti RJ, Pfeiffer RF, Trenkwalder C, Homann N, Ott E, Wenzel K, Asmus F, Hardy J, Wszolek Z, Gasser T

Abstract

Recently, a new locus (PARK8) for autosomal dominant parkinsonism has been identified in one large Japanese family. Linkage has been shown to a 16-cM centromeric region of chromosome 12, between markers D12S1631 and D12S339. We tested 21 white families with Parkinson disease and an inheritance pattern compatible with autosomal dominant transmission for linkage in this region. Criteria for inclusion were at least three affected individuals in more than one generation. A total of 29 markers were used to saturate the candidate region. One hundred sixty-seven family members were tested (84 affected and 83 unaffected). Under the assumption of heterogeneity and through use of an affecteds-only model, a maximum multipoint LOD score of 2.01 was achieved in the total sample, with an estimated proportion of families with linkage of 0.32. This LOD score is significant for linkage in a replication study and corresponds to a P value of.0047. Two families (family A [German Canadian] and family D [from western Nebraska]) reached significant linkage on their own, with a combined maximum multipoint LOD score of 3.33, calculated with an affecteds-only model (family A: LOD score 1.67, P=.0028; family D: LOD score 1.67, P=.0028). When a penetrance-dependent model was calculated, the combined multipoint LOD score achieved was 3.92 (family A: LOD score 1.68, P=.0027; family D: LOD score 2.24, P=.0007). On the basis of the multipoint analysis for the combined families A and D, the 1-LOD support interval suggests that the most likely disease location is between a CA repeat polymorphism on genomic clone AC025253 (44.5 Mb) and marker D12S1701 (47.7 Mb). Our data provide evidence that the PARK8 locus is responsible for the disease in a subset of families of white ancestry with autosomal dominant parkinsonism, suggesting that it could be a more common locus.

MeSH Terms
Chromosome Mapping Female Genes, Dominant Humans Male Parkinson Disease/diagnostic imaging,genetics Pedigree Tomography, Emission-Computed Whites
Authors & Affiliations
21 authors, click to expand affiliations / ORCID
Zimprich Alexander
Hertie-Institute for Clinical Brain Research, Department for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany.
Müller-Myhsok Bertram
Farrer Matthew
Leitner Petra
Sharma Manu
Hulihan Mary
Lockhart Paul
Strongosky Audrey
Kachergus Jennifer
Calne Donald B
Stoessl Jon
Uitti Ryan J
Pfeiffer Ronald F
Trenkwalder Claudia
Homann Nikolaus
Ott Erwin
Wenzel Karoline
Asmus Friedrich
Hardy John
Wszolek Zbigniew
Gasser Thomas
References (40)
40 references, click to expand
  1. Steele-Richardson-Olszewski syndrome in a patient with a single C212Y mutation in the parkin protein.
    Mov Disord. 2002 Nov;17(6):1374-80 PMID: 12465088
  2. Familial parkinsonism: Our experience and review.
    Parkinsonism Relat Disord. 1995 Jul;1(1):35-46 PMID: 18590999
  3. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.
    Nat Genet. 2000 Jul;25(3):302-5 PMID: 10888878
  4. Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease.
    Neurology. 1999 Nov 10;53(8):1858-60 PMID: 10563640
  5. Complete genomic screen in Parkinson disease: evidence for multiple genes.
    JAMA. 2001 Nov 14;286(18):2239-44 PMID: 11710888
  6. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.
    Science. 2003 Jan 10;299(5604):256-9 PMID: 12446870
  7. Lewy bodies and parkinsonism in families with parkin mutations.
    Ann Neurol. 2001 Sep;50(3):293-300 PMID: 11558785
  8. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.
    Nat Genet. 1998 Feb;18(2):106-8 PMID: 9462735
  9. The ubiquitin pathway in Parkinson's disease.
    Nature. 1998 Oct 1;395(6701):451-2 PMID: 9774100
  10. Age at onset in two common neurodegenerative diseases is genetically controlled.
    Am J Hum Genet. 2002 Apr;70(4):985-93 PMID: 11875758
  11. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.
    Nature. 1998 Apr 9;392(6676):605-8 PMID: 9560156
  12. Parkinson's Disease Society Brain Bank, London: overview and research.
    J Neural Transm Suppl. 1993;39:165-72 PMID: 8360656
  13. Clinical and neuropathological aspects of autosomal recessive juvenile parkinsonism.
    J Neurol. 1998 Nov;245(11 Suppl 3):P4-9 PMID: 9808334
  14. alpha-Synuclein gene haplotypes are associated with Parkinson's disease.
    Hum Mol Genet. 2001 Aug 15;10(17):1847-51 PMID: 11532993
  15. Parkinson's genetics: molecular insights for the new millennium.
    Neurotoxicology. 2002 Oct;23(4-5):503-14 PMID: 12428722
  16. Genome-wide scan for Parkinson's disease: the GenePD Study.
    Neurology. 2001 Sep 25;57(6):1124-6 PMID: 11571351
  17. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.
    Science. 1997 Jun 27;276(5321):2045-7 PMID: 9197268
  18. Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity.
    Am J Hum Genet. 2000 Mar;66(3):922-32 PMID: 10712207
  19. Western Nebraska family (family D) with autosomal dominant parkinsonism.
    Neurology. 1995 Mar;45(3 Pt 1):502-5 PMID: 7898705
  20. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
    J Neuropathol Exp Neurol. 2003 Apr;62(4):389-97 PMID: 12722831
  21. Dementia with Lewy bodies in Down's syndrome.
    Int J Geriatr Psychiatry. 2001 Mar;16(3):311-20 PMID: 11288166
  22. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 1997 Jan;62(1):10-5 PMID: 9010393
  23. Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations.
    Neurology. 2001 Feb 27;56(4):555-7 PMID: 11222808
  24. Criteria for diagnosing Parkinson's disease.
    Ann Neurol. 1992;32 Suppl:S125-7 PMID: 1510370
  25. TESTING FOR HETEROGENEITY OF RECOMBINATION FRACTION VALUES IN HUMAN GENETICS.
    Ann Hum Genet. 1963 Nov;27:175-82 PMID: 14081488
  26. Genetic complexity and Parkinson's disease.
    Science. 1997 Jul 18;277(5324):388-9; author reply 389 PMID: 9518367
  27. The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease.
    Neuropathol Appl Neurobiol. 1989 Jan-Feb;15(1):27-44 PMID: 2542825
  28. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1.
    Ann Neurol. 2002 Mar;51(3):296-301 PMID: 11891824
  29. Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred.
    Acta Neuropathol. 2002 Jul;104(1):7-11 PMID: 12070658
  30. Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies.
    Acta Neuropathol. 2000 Nov;100(5):568-74 PMID: 11045680
  31. Neuropathology of Gerstmann-Sträussler-Scheinker disease.
    Microsc Res Tech. 2000 Jul 1;50(1):10-5 PMID: 10871543
  32. German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - Longitudinal observations.
    Parkinsonism Relat Disord. 1997 Nov;3(3):125-39 PMID: 18591067
  33. Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations.
    Am J Hum Genet. 2002 Jul;71(1):124-35 PMID: 12058349
  34. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23.
    Science. 1996 Nov 15;274(5290):1197-9 PMID: 8895469
  35. Lewy bodies in the brain of two members of a family with the 717 (Val to Ile) mutation of the amyloid precursor protein gene.
    Neurosci Lett. 1994 May 19;172(1-2):77-9 PMID: 8084541
  36. Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q.
    Neurology. 1998 Sep;51(3):890-2 PMID: 9748052
  37. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results.
    Nat Genet. 1995 Nov;11(3):241-7 PMID: 7581446
  38. Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation.
    Ann Neurol. 2001 Mar;49(3):313-9 PMID: 11261505
  39. Molecular genetics of familial parkinsonism.
    Parkinsonism Relat Disord. 1999 Dec;5(4):145-55 PMID: 18591133
  40. A susceptibility locus for Parkinson's disease maps to chromosome 2p13.
    Nat Genet. 1998 Mar;18(3):262-5 PMID: 9500549
Article Info
Journal
American journal of human genetics
Abbr.
Am J Hum Genet
ISSN
0002-9297
Published
2004-01-00
Epub
2003-00-19
Pages
11-9
Language
English
Region
United States
NLM ID
0370475
PMCID
PMC1181898
Subset
IM
Grants
NINDS NIH HHS · P01 NS040256 · United States
NINDS NIH HHS · P50 NS040256 · United States
NINDS NIH HHS · NS 40256 · United States
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com